8 results match your criteria: "Renal Section and Center for Health Equity Research and Promotion[Affiliation]"
Association of Symptoms and Collaborative Care Intervention with Systemic Inflammation Biomarkers in ESKD.
Kidney360
September 2024
Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Article Synopsis
- The study looked at patients with end-stage kidney disease (ESKD) and found no links between inflammation markers and their feelings of pain, tiredness, or sadness at the start.
- A special treatment called Technology-Assisted stepped Collaborative Care (TĀCcare) helped reduce inflammation for some patients over a short time.
- Both the treatment and regular groups saw changes in certain inflammation markers, but only the treatment group showed improvements in specific markers like TNF- and IL-2 at 3 months.
Correlates of Rates and Treatment Readiness for Depressive Symptoms, Pain, and Fatigue in Hemodialysis Patients: Results from the TĀCcare Study.
Kidney360
September 2023
Renal-Electrolyte Division , Department of Medicine , University of Pittsburgh School of Medicine, Pittsburgh , Pennsylvania.
Key Points: Lower neighborhood walkability was associated with higher depressive symptoms and fatigue and younger age with depressive symptoms. Depressive symptoms, pain, and fatigue were frequently reported, often occurred together, and were often not all already treated. Patients with a higher symptom burden and men may be more likely to be ready to seek treatment for depressive symptoms, pain, or fatigue.
View Article and Find Full Text PDFEffects of Technology Assisted Stepped Collaborative Care Intervention to Improve Symptoms in Patients Undergoing Hemodialysis: The TĀCcare Randomized Clinical Trial.
JAMA Intern Med
August 2023
Division of Nephrology, Department of Internal Medicine, University of New Mexico School of Medicine Albuquerque.
Importance: Patients with end-stage kidney disease (ESKD) undergoing long-term hemodialysis often experience a high burden of debilitating symptoms for which effective treatment options are limited.
Objective: To compare the effectiveness of a stepped collaborative care intervention vs attention control for reducing fatigue, pain, and depression among patients with ESKD undergoing long-term hemodialysis.
Design, Setting, And Participants: Technology Assisted Stepped Collaborative Care (TĀCcare) was a parallel-group, single-blinded, randomized clinical trial of adult (≥18 years) patients undergoing long-term hemodialysis and experiencing clinically significant levels of fatigue, pain, and/or depression for which they were considering treatment.
Web Exclusive. Annals for Hospitalists Inpatient Notes - Preventing Contrast-Associated Acute Kidney Injury-Putting the Issue to Rest.
Ann Intern Med
July 2019
The George Institute for Global Health, Sydney Australia (M.G.).
Contrast-associated acute kidney injury is a myth: No.
Intensive Care Med
January 2018
CHU de Caen, Service de Réanimation Medicale, Caen, France.
Symptom burden, depression, and quality of life in chronic and end-stage kidney disease.
Clin J Am Soc Nephrol
June 2009
Renal Section and Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania 15240, USA.
Background And Objectives: While many patients with end-stage renal disease (ESRD) have impaired physical and psychologic well-being, less is known about these health domains in patients with advanced chronic kidney disease (CKD). The authors sought to compare symptoms, depression, and quality of life in patients with ESRD and those with CKD.
Design, Setting, Participants, & Measurements: Patients with ESRD and subjects with advanced CKD were enrolled.
Iodinated contrast media and the kidney.
Rev Cardiovasc Med
July 2008
Renal Section and Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA.
One of the principal complications of radiographic procedures utilizing intravascular iodinated contrast media is acute kidney injury. Although several clinical and procedural factors impact a patient's risk for contrast-induced acute kidney injury (CIAKI), substantial attention has been focused on the relationship between the type of contrast agent used and renal injury. Multiple contrast agents are available for clinical use, each defined by a series of physicochemical properties.
View Article and Find Full Text PDFThe incidence of clinically significant contrast-induced nephropathy following non-emergent coronary angiography.
Catheter Cardiovasc Interv
June 2008
Renal Section and Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA 15214, USA.
Objectives: The primary aim of this study was to assess the incidence of clinically significant contrast-induced nephropathy (CIN) among patients undergoing non-emergent coronary angiography.
Background: Although retrospective analyses have emphasized the association of CIN with adverse patient outcomes, the actual incidence of clinically significant CIN following non-emergent coronary angiography is not clear.
Methods: We prospectively identified patients with baseline estimated glomerular filtration rates (eGFR) < 60 ml/min/1.